Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Toscano

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1992
Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptorsC Lubrano, F Sciarra, G Spera, et al.
Clinical Endocrinology|October 1, 1985
Familial male pseudohermaphroditism with gynaecomastia due to 17 beta-hydroxysteroid dehydrogenase deficiency. A report of 3 casesR Balducci, V Toscano, F Wright, et al.
Hormone Research|May 6, 1998
Effects of long-term growth hormone therapy on adrenal steroidogenesis in Turner syndromeR Balducci, V Toscano, D Larizza, et al.
Journal of Andrology|December 31, 1997
Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamideS Monti, F Sciarra, M V Adamo, et al.
European Journal of Endocrinology|January 1, 1995
Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapyR Balducci, V Toscano, A M Pasquino, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activityP Moghetti, R Castello, C Negri, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 1, 1993
Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasiaC Lubrano, V Toscano, E Petrangeli, et al.
Endocrine-Related Cancer|March 4, 2008
Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotaneA Stigliano, L Cerquetti, M Borro, et al.
The Prostate|October 6, 1998
Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasiaF Di Silverio, S Monti, A Sciarra, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgensS Monti, F Di Silverio, R Iraci, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Steroid Biochemistry and Molecular Biology|March 1, 1992
Immunoreactive EGF in human benign prostatic hyperplasia: relationships with androgen and estrogen receptorsC Lubrano, F Sciarra, G Spera, et al.
Clinical Endocrinology|October 1, 1985
Familial male pseudohermaphroditism with gynaecomastia due to 17 beta-hydroxysteroid dehydrogenase deficiency. A report of 3 casesR Balducci, V Toscano, F Wright, et al.
Hormone Research|May 6, 1998
Effects of long-term growth hormone therapy on adrenal steroidogenesis in Turner syndromeR Balducci, V Toscano, D Larizza, et al.
Journal of Andrology|December 31, 1997
Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamideS Monti, F Sciarra, M V Adamo, et al.
European Journal of Endocrinology|January 1, 1995
Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapyR Balducci, V Toscano, A M Pasquino, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activityP Moghetti, R Castello, C Negri, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 1, 1993
Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasiaC Lubrano, V Toscano, E Petrangeli, et al.
Endocrine-Related Cancer|March 4, 2008
Modulation of proteomic profile in H295R adrenocortical cell line induced by mitotaneA Stigliano, L Cerquetti, M Borro, et al.
The Prostate|October 6, 1998
Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasiaF Di Silverio, S Monti, A Sciarra, et al.
The Journal of Clinical Endocrinology and Metabolism|April 12, 2001
Regional variations of insulin-like growth factor I (IGF-I), IGF-II, and receptor type I in benign prostatic hyperplasia tissue and their correlation with intraprostatic androgensS Monti, F Di Silverio, R Iraci, et al.
Pageof 10